DJIA 17,760.85 14.87 0.08%
NASDAQ 5,149.48 20.69 0.40%
S&P 500 2,112.41 3.78 0.18%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

178.30 6.61 (3.85%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $178.45 3.94%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $177.50
Previous Close $171.69
Daily Range $176.50 - $181.81
52-Week Range $124.76 - $181.81
Market Cap $135.6B
P/E Ratio 23.17
Dividend (Yield) $3.16 (1.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,441,579
Average Daily Volume 3,366,491
Current FY EPS $9.61




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release

The next big catalyst is right around the corner for Amgen. Find out what important questions you should be asking as Amgen readies to report its second-quarter earnings results on July 30.

Amgen Beats on Q2 Earnings & Revenues, Raises Outlook - Analyst Blog

Nasdaq 100 Movers: WFM, AMGN

Tech Stock Owners Looking For Excuses To Take Profit

Stocks Hitting 52-Week Highs

Amgen (AMGN) Earnings Report: Q2 2015 Conference Call Transcript

Stocks Up After Wage Data Calls September Rate Hike Into Question

Today's Market: Biotech Earnings Remain Strong, Apple's Next Revamped Product

Fast Money Picks For July 31

Key Takeaways from Amgen's (AMGN) Q2 Earnings Report - Stocks in the News

Amgen (AMGN) Robert A. Bradway on Q2 2015 Results - Earnings Call Transcript

See More AMGN News...

AMGN's Top Competitors

AMGN $178.30 (3.85%)
Current stock: AMGN
GILD $118.19 (0.25%)
Current stock: GILD
CELG $132.52 (0.49%)
Current stock: CELG
$0.00 (0.00%)
Current stock: